ARGENX SE is 6.5x more valuable than BIO-TECHNE Corp by market capitalization ($53.35 B vs $8.22 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TECH | ARGX |
|---|---|---|
| Market cap | $8.22 B | $53.35 B |
| US-listed rank | #1055 | #306 |
| Revenue (latest FY) | $1.22B | - |
| Net income (latest FY) | $73.40M | - |
| Net margin | 6.0% | - |
| P/E (trailing FY) | 112.0 | - |
| SEC filings | 1,229 | 272 |
ARGENX SE is 6.5x more valuable than BIO-TECHNE Corp by market capitalization ($53.35 B vs $8.22 B).
Full pages: BIO-TECHNE Corp and ARGENX SE, or browse the full rankings.